AAAAAA

   
Results: 1-11 |
Results: 11
Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure
Authors: Miller, V Larder, BA
Citation: V. Miller et Ba. Larder, Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure, ANTIVIR TH, 6, 2001, pp. 25-44
World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing
Authors: Harrigan, PR Montaner, JSG Wegner, SA Verbiest, W Miller, V Wood, R Larder, BA
Citation: Pr. Harrigan et al., World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing, AIDS, 15(13), 2001, pp. 1671-1677
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samplesfrom heavily treated patients
Authors: Shafer, RW Hertogs, K Zolopa, AR Warford, A Bloor, S Betts, BJ Merigan, TC Harrigan, R Larder, BA
Citation: Rw. Shafer et al., High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samplesfrom heavily treated patients, J CLIN MICR, 39(4), 2001, pp. 1522-1529
Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine
Authors: Lennerstrand, J Stammers, DK Larder, BA
Citation: J. Lennerstrand et al., Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine, ANTIM AG CH, 45(7), 2001, pp. 2144-2146
Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type1 mutants
Authors: Lennerstrand, J Hertogs, K Stammers, DK Larder, BA
Citation: J. Lennerstrand et al., Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type1 mutants, J VIROLOGY, 75(15), 2001, pp. 7202-7205
Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples
Authors: Hertogs, K Bloor, S Kemp, SD Van den Eynde, C Alcorn, TM Pauwels, R Van Houtte, M Staszewski, S Miller, V Larder, BA
Citation: K. Hertogs et al., Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples, AIDS, 14(9), 2000, pp. 1203-1210
Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples
Authors: Larder, BA Hertogs, K Bloor, S van den Eynde, C DeCian, W Wang, YY Freimuth, WW Tarpley, G
Citation: Ba. Larder et al., Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples, AIDS, 14(13), 2000, pp. 1943-1948
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V
Authors: Hertogs, K Bloor, S De Vroey, V Van den Eynde, C Dehertogh, P Van Cauwenberge, A Sturmer, M Alcorn, T Wegner, S Van Houtte, M Miller, V Larder, BA
Citation: K. Hertogs et al., A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V, ANTIM AG CH, 44(3), 2000, pp. 568-573
Closing in on HIV drug resistance
Authors: Larder, BA Stammers, DK
Citation: Ba. Larder et Dk. Stammers, Closing in on HIV drug resistance, NAT ST BIOL, 6(2), 1999, pp. 103-106
The rabbit study: Ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients
Authors: Churchill, DR Pym, AS Galpin, S Foxall, R Stainsby, C Clarke, JR Kaye, S Bloor, S Larder, BA Wills, B Sun, E Babiker, AG Back, DJ Weber, JN
Citation: Dr. Churchill et al., The rabbit study: Ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients, AIDS RES H, 15(13), 1999, pp. 1181-1189
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
Authors: Larder, BA Bloor, S Kemp, SD Hertogs, K Desmet, RL Miller, V Sturmer, M Staszewski, S Ren, J Stammers, DK Stuart, DI Pauwels, R
Citation: Ba. Larder et al., A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance, ANTIM AG CH, 43(8), 1999, pp. 1961-1967
Risultati: 1-11 |